MNKKQ Mallinckrodt Plc

About MNKKQ

Keenova Therapeutics Plc engages in the development, manufacture, marketing, and distribution of both branded and generic specialty pharmaceutical products. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment markets branded pharmaceutical products for autoimmune and rare diseases in the specialty areas of neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; and gastrointestinal products. The Specialty Generics segment consists of niche specialty generic drugs and active pharmaceutical ingredients. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Dublin, Ireland.

Bullish Sentiment

How do you feel about MNKKQ?